FI893765A - Foerfarande foer framstaellning av en fysiologiskt aktiv substans som mot verkar cancer. - Google Patents

Foerfarande foer framstaellning av en fysiologiskt aktiv substans som mot verkar cancer. Download PDF

Info

Publication number
FI893765A
FI893765A FI893765A FI893765A FI893765A FI 893765 A FI893765 A FI 893765A FI 893765 A FI893765 A FI 893765A FI 893765 A FI893765 A FI 893765A FI 893765 A FI893765 A FI 893765A
Authority
FI
Finland
Prior art keywords
cancer
verkar
fysiologiskt
substans
aktiv
Prior art date
Application number
FI893765A
Other languages
English (en)
Other versions
FI893765A0 (fi
FI100457B (fi
Inventor
Ichiei Sato
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of FI893765A0 publication Critical patent/FI893765A0/fi
Publication of FI893765A publication Critical patent/FI893765A/fi
Application granted granted Critical
Publication of FI100457B publication Critical patent/FI100457B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Peptides Or Proteins (AREA)
FI893765A 1988-08-10 1989-08-09 Menetelmä Cohnin V:n fraktion käsittävän koostumuksen valmistamiseksi FI100457B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19968888 1988-08-10
JP63199688A JPH0688906B2 (ja) 1988-08-10 1988-08-10 制癌作用を有する生物活性物質の製造方法およびそれにより得られる制癌作用を有する生物活性物質

Publications (3)

Publication Number Publication Date
FI893765A0 FI893765A0 (fi) 1989-08-09
FI893765A true FI893765A (fi) 1990-02-11
FI100457B FI100457B (fi) 1997-12-15

Family

ID=16411959

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893765A FI100457B (fi) 1988-08-10 1989-08-09 Menetelmä Cohnin V:n fraktion käsittävän koostumuksen valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0354492B1 (fi)
JP (1) JPH0688906B2 (fi)
KR (1) KR940003053B1 (fi)
AT (1) ATE110733T1 (fi)
AU (1) AU616548B2 (fi)
CA (1) CA1326996C (fi)
DE (1) DE68917830T2 (fi)
DK (1) DK386689A (fi)
ES (1) ES2059656T3 (fi)
FI (1) FI100457B (fi)
HK (1) HK1005190A1 (fi)
HU (1) HU205257B (fi)
IL (1) IL91251A (fi)
NO (1) NO179327C (fi)
NZ (1) NZ230250A (fi)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
JPS57140725A (en) * 1981-12-28 1982-08-31 Dainippon Pharmaceut Co Ltd Physiologically active substance having carcinostatic action
JPS58141785A (ja) * 1982-02-16 1983-08-23 Nippon Shinyaku Co Ltd 抗腫瘍物質の製法
JPS5982315A (ja) * 1982-11-02 1984-05-12 Yamanouchi Pharmaceut Co Ltd 腫瘍壊死因子の製造法
JPS6067429A (ja) * 1983-09-22 1985-04-17 Sendai Biseibutsu Kenkyusho 生理活性物質の製造法
JPS6248631A (ja) * 1985-08-26 1987-03-03 Dai Ichi Seiyaku Co Ltd 抗腫瘍血清因子
JPS6256430A (ja) * 1985-09-04 1987-03-12 Takeda Chem Ind Ltd 抗腫瘍性酸性糖蛋白

Also Published As

Publication number Publication date
DK386689A (da) 1990-02-11
HUT53808A (en) 1990-12-28
ES2059656T3 (es) 1994-11-16
KR940003053B1 (ko) 1994-04-13
FI893765A0 (fi) 1989-08-09
IL91251A0 (en) 1990-03-19
HU205257B (en) 1992-04-28
EP0354492B1 (en) 1994-08-31
AU616548B2 (en) 1991-10-31
CA1326996C (en) 1994-02-15
NO179327B (no) 1996-06-10
KR900002790A (ko) 1990-03-23
IL91251A (en) 1994-12-29
AU3936589A (en) 1990-02-15
EP0354492A3 (en) 1990-08-01
HK1005190A1 (en) 1998-12-24
DK386689D0 (da) 1989-08-07
ATE110733T1 (de) 1994-09-15
JPH0688906B2 (ja) 1994-11-09
FI100457B (fi) 1997-12-15
NO893194D0 (no) 1989-08-08
JPH0248532A (ja) 1990-02-19
NO179327C (no) 1996-09-18
NO893194L (no) 1990-02-12
EP0354492A2 (en) 1990-02-14
DE68917830D1 (de) 1994-10-06
DE68917830T2 (de) 1994-12-22
NZ230250A (en) 1992-09-25

Similar Documents

Publication Publication Date Title
Waziri Glycine therapy of schizophrenia.
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
DE59209907D1 (de) Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE69433013D1 (de) Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
CA2091789A1 (en) Method of inhibiting microvascular thrombosis
ATE194497T1 (de) Monoklonale antikoerper gegen lfa-1 zur herstellung eines arzneimittels zur vorbeugung der transplantatabstossung von organen
DE69013797D1 (de) Gehirnspezifische Zubereitung mit gesteuerter Abgabe.
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
FI893765A0 (fi) Foerfarande foer framstaellning av en fysiologiskt aktiv substans som mot verkar cancer.
Storey Tetracycline antibiotics and their effects on calcified and non‐calcified tissues
Doody et al. Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts.
RU93004848A (ru) Вещества растительного происхождения, обладающие противоопухолевой активностью, фармацевтические препараты на их основе, способы их получения
DE69123344D1 (de) Künstliches blutgefäss sowie herstellung desselben
DK76488D0 (da) Fremgangsmaade til foroegelse af effektiviteten af vegativ formering af kartofler in vitro
Rogo A case of mysterious stone-throwing in Arizona.
PT79249A (de) In position b 30 modifizierte insulin-derivate verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
Kowalewski et al. Effect of antrectomy on the response of stomach to histamine and pentagastrin in rats
Godfrey Mechanism of formation of non-immune rosettes between guinea-pig thymus-derived lymphocytes and rabbit erythrocytes.
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
Von Kifor et al. Beiträge zur Untersuchung der Wirkung von Trasylol: I. Einfluß von Trasylol auf Migration und Degranulation der neutrophilen Granulozyten, Vergleich mit Prednisolon
AU1568995A (en) Analogs of thymosin alpha1
NO833986L (no) Kunstig "bukspyttkjertel" for implantering i menneskekroppen for injisering av insulin som funksjon av det momentane blodsukkeret til enhver tid
IL88538A0 (en) Use of narrow band-width light for the potentiation of plant propagation in tissue culture
RU96112682A (ru) Метод лечения неврологических больных внутривенным введением фетальных клеток человека

Legal Events

Date Code Title Description
FG Patent granted

Owner name: BIO DEFENCE INSTITUTE CO., LTD

GB Transfer or assigment of application

Owner name: BIO DEFENCE INSTITUTE CO., LTD

MM Patent lapsed

Owner name: BIO DEFENCE INSTITUTE CO., LTD